We have collected information about Phares Drug Delivery Ag for you. Follow the links to find out details on Phares Drug Delivery Ag.
https://scrip.pharmaintelligence.informa.com/companies/200400754
Phares Drug Delivery AG Email Company All set! This article has been sent to [email protected]. All fields are required. For multiple recipients, separate email addresses with a semicolon. Please make sure all fields are completed. Please enter a valid e-mail address …
http://www.hormonebalance.org/images/documents/McLennan%2005%20sub%20C%20delivery%20DDT.pdf
Subcutaneous drug delivery and the role of the lymphatics Danielle N. McLennan1, Christopher J.H. Porter2, Susan A. Charman1,* 1Centre for Drug Candidate Optimisation, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville, Vic. 3052, Australia
https://www.manufacturingchemist.com/company/single_company/Phares_Drug_Delivery_AG
www.phares.biz. PO Box 637 Kluenenfeldstrasse 30 Muttenz CH-4132 Switzerland +41 61 317 9040
https://www.in-pharmatechnologist.com/Article/2004/07/26/Phares-licenses-novel-drug-delivery-tech-to-aerosol-drug-maker
A US-based aerosol drug specialist has signed an agreement with Switzerland's Phares Drug Delivery for use of a technology that can improve the delivery of inhalation-therapy drugs and overcome delivery incompatibility in combination products.
https://www.linkedin.com/in/jacques-quinton-869b3617
View Jacques Quinton’s profile on LinkedIn, the world's largest professional community. Jacques has 2 jobs listed on their profile. ... Phares Drug Delivery AG. University of Nantes Faculty of ...Title: Fellow in Formulation At Novartis
https://www.sciencedirect.com/science/article/pii/S1740674905000119
Drug administration by SC injection results in delivery to the interstitial area underlying the dermis of the skin. The interstitium consists of a fibrous collagen network supporting a gel-phase comprising negatively charged glycosaminoglycans (largely hyaluronan), salts and plasma-derived proteins [ 1 , 2 ].Author: Danielle N McLennan, Christopher John H Porter, Susan A Charman
https://2019.controlledreleasesociety.org/program/speakers/peter-van-hoogevest
In 2000 he joined Phares Drug Delivery AG (Muttenz, CH), a company specialized in the delivery of poorly water soluble drug substances, as Managing Director and COO and member of the Board of Directors. Since 2012 he is Managing Director of the Phospholipid Research Center, Heidelberg and Head of the Scientific Department (including the ...
https://www.sciencedirect.com/science/article/pii/S0928098712001844
Aug 30, 2012 · The poorly water-soluble drug ABT-102, a potent TRPV1 (transient receptor potential cation channel subfamily V member 1) antagonist, was investigated in terms of its solubility and dissolution-permeation rate across Caco-2 cell monolayers in the presence and absence of fasted state simulated intestinal fluid (FaSSIF).Author: Kerstin J. Frank, Kerstin J. Frank, Ulrich Westedt, Karin M. Rosenblatt, Peter Hölig, Jörg Rosenberg...
https://www.azonano.com/suppliers.aspx?SupplierID=2146
Phares AG, located in Basel, Switzerland provides a range of services and products to develop dosage forms for insoluble compounds. Phares 360 services (www.Phares360.com) include pharmaceutical profiling for lead selection (Survey), rapid solutions for tox testing (Speed) and developing clinical formulations with enhanced bioavailability (Icebreaker).Location: PO Box 637, Kluenenfeldstrasse 30, CH-4132, Muttenz
http://europepmc.org/patents/PAT/EP1476137
COMPOSITION COMPRISING LOW WATER SOLUBLE COMPOUNDS WITHIN POROUS CARRIERS (PAT - EP1476137) ' ' Leigh Steve Phares Drug Delivery AG, ' ' ... Leigh Steve Phares Drug Delivery AG, ' ' Leigh Mathew Louis Steven, ' ' Van Hoogevest Peter, ' ' Tiemessen Henricus, ' ' Quinton Jacques Patent: Publ. of Application with search ...
Searching for Phares Drug Delivery Ag?
You can just click the links above. The data is collected for you.
